Cures Vs. Profits: Successes In Translational Research
5 ratings by Goodreads
Language: English
Published by Wspc, 2016
- Softcover
- Used

Seller: Blindpig Books, salt lake city, UT, U.S.A.Blindpig Books
5-star seller
AbeBooks seller since March 27, 2012
Softcover
Condition: Used - Good
US$ 6.54
US$ 3.99 shipping
Ships within U.S.A.
Quantity: 1 available
Add to basketFree 30-day returns
Item description from seller
Some light wear. Good copy.
Seller Inventory # 25-10-08-gw-46771-lcz
- Title
- Cures Vs. Profits: Successes In Translational Research
- Author
- Lyons-Weiler, James
- Publisher
- Wspc
- Publication year
- 2016
- Condition
- Used - Good
- Binding
- paperback
- Language
- English
- ISBN 10
- 9814730149
- ISBN 13
- 9789814730143
- Edition
- Reprint.
- Item weight
- 1 ounce
- Dimensions
- 6x0x9
Did you ever wonder whether doctors want cures, or just treatments?
Did you know ...
Grapefruit can interact with over 100 drugs, but it may be useful for reducing blood pressure and for weight loss?
ADHD over diagnosis is now recognized widely as a fact, and there are existing -- and new ways -- to avoid a misdiagnosis?
Studies have been conducted demonstrating the utility of Omega 3 fatty acids, meditation, yoga, and melatonin for some important symptoms of ADHD, including executive functions?
Vaccines have saved millions of lives in the last decade? But are the safe?
Breast cancer rates are declining in the US, but have been steadily increasing in Japan?
Doctors are getting better at predicting which chemotherapy will, and will not work, on certain cancers?
There are vaccines against cancer?
This book reviews recent key, hard-won successes and findings from recent biomedical research. Written by one of the most ardent defenders of the public trust in science, it provides an accessible, detailed look at successes in translational biomedical and clinical research. The author provides an optimistic, forward-looking view for the possibility of change for the public good, cutting through the controversy and gets to very core of each topic. The public can be optimistic about the future of medicine, but only if they learn the facts of these advances, and learn what their doctors should be expected to know.
Highly referenced, and filled with interviews from experts and people directly involved in the research behind the new facts in each chapter, this book is a rich source of information on advances in biomedicine that you will want to share with your family & friends.
Readership: Lay public, scientists, doctors, politicians, policy makers, public health workers, health care worker, investors.
Did you know ...
Highly referenced, and filled with interviews from experts and people directly involved in the research behind the new facts in each chapter, this book is a rich source of information on advances in biomedicine that you will want to share with your family & friends.
Readership: Lay public, scientists, doctors, politicians, policy makers, public health workers, health care worker, investors.
"Synopsis" may belong to another edition of this title.
About the Author
Dr Lyons-Weiler is an author and biomedical research scientist from Western Pennsylvania, USA. This is his second book. His first book, "Ebola: An Evolving Story" provides an in-depth analysis of the interplay between faith, belief, fear, dogma, science, reason, and policy during the world's first Ebola pandemic.
"About the title" may belong to another edition of this title.
Blindpig Books
salt lake city, UT, U.S.A.
5-star seller
AbeBooks seller since March 27, 2012
Shipping rates within U.S.A.
| Item | 5 to 14 business days | 3 to 6 business days |
|---|---|---|
| First item | US$ 3.99 | US$ 9.99 |
Payment methods
Seller's business information
Blindpig Books
UT, U.S.A.
Terms of sale
Media mail $3.99 hardback, $3.59 paperback; $1.99 for each additional book.
Priority mail $6.99 first book, $1.99 each additional.
Shipping terms
Shipping costs are based on books weighing 2.2 LB, or 1 KG. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.